Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.

Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,143 · see citing works

GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons

Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S. L., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,206 · see citing works

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

Hyman, C., Hofer, M., Barde, Y., Juhasz, M., Yancopoulos, G. D., Squinto, S. P., & Lindsay, R. M. (1991) · Nature · doi:10.1038/350230a0 · Cited by 1,494 · see citing works

GDNF: a Potent Survival Factor for Motoneurons Present in Peripheral Nerve and Muscle

Henderson, C. E., PHILLIPS, H. S., Pollock, R. A., Davies, A. M., Lemeulle, C., Armanini, M. P., Simmons, L. C., Moffet, B., Vandlen, R. A., Koliatsos, V. E., et al. (1994) · Science · doi:10.1126/science.7973664 · Cited by 1,273 · see citing works

Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development

Jones, K. R., Fariñas, I., Backus, C., & Reichardt, L. F. (1994) · Cell · doi:10.1016/0092-8674(94)90377-8 · Cited by 1,041 · see citing works

Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice

Heikkila, R. E., Hess, A., & Duvoisin, R. C. (1984) · Science · doi:10.1126/science.6610213 · Cited by 1,010 · see citing works

Brain‐Derived Neurotrophic Factor Protects Dopamine Neurons Against 6‐Hydroxydopamine and N‐Methyl‐4‐Phenylpyridinium Ion Toxicity: Involvement of the Glutathione System

Spina, M. B., Squinto, S. P., Miller, J. M., Lindsay, R. M., & Hyman, C. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08880.x · Cited by 460 · see citing works

Glial Cell Line-Derived Neurotrophic Factor Is Expressed in the Developing but Not Adult Striatum and Stimulates Developing Dopamine Neurons in Vivo

Strömberg, I., Björklund, L., Johansson, M. H., Tomac, A. C., Collins, F., Olson, L., Hoffer, B. J., & Humpel, C. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1214 · Cited by 380 · see citing works

Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice

OTTO, D., & Unsicker, K. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-06-01912.1990 · Cited by 367 · see citing works

Regional and Cell-Specific Expression of GDNF in Rat Brain

Schaar, D. G., Sieber, B.-A., Dreyfus, C. F., & Black, I. B. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1207 · Cited by 272 · see citing works

Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57 BL/6 mice. Comparison with three other strains of mice

̈m, E. S., Stro¨mberg, I., Tsutsumi, T., et al. (1987) · Brain Research · doi:10.1016/0006-8993(87)90986-3 · Cited by 204 · see citing works

The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth FACTOR-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture

Beck, K. D., Knüsel, B., & Hefti, F. F. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90534-m · Cited by 176 · see citing works

Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger rna in response to kainate-induced excitation

Humpel, C., Hoffer, B. J., Strömberg, I., Bektesh, S. L., Collins, F., & Olson, L. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90284-4 · Cited by 154 · see citing works

Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease

Sundström, E., Fredriksson, A., & Archer, T. (1990) · Brain Research · doi:10.1016/0006-8993(90)91656-2 · Cited by 145 · see citing works

Glial cell-line derived neurotrophic factor (GDNF) mRNA upregulation in striatum and cortical areas after pilocarpine-induced status epilepticus in rats

Schmidt‐Kastner, R., Tomac, A., Hoffer, B. J., Bektesh, S. L., Rosenzweig, B., & Olson, L. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90106-6 · Cited by 107 · see citing works

Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture

Nikkhah, G., Odin, P., Smits, A. M., Tingstr�m, A., Othberg, A. I., Brundin, P., Funa, K., & Lindvall, O. (1993) · Experimental Brain Research · doi:10.1007/bf00229041 · Cited by 103 · see citing works

Epidermal growth factor exerts neuronotrophic effects on dopaminergic and GABAergic CNS neurons: Comparison with basic fibroblast growth factor

Ferrari, G. V. D., Toffano, G., & Skaper, S. D. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490300306 · Cited by 94 · see citing works

Convergent regulation by ciliary neurotrophic factor and dopamine of tyrosine hydroxylase expression in cultures of rat substantia nigra

Magal, E., Burnham, P., Varon, S. S., & Louis, J. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90535-n · Cited by 53 · see citing works

BEHAVIOURAL EFFECTS OF ERGOT DRUGS

Ögren, S. O., Köhler, C., Fuxé, K., et al. (1979) · Elsevier eBooks · doi:10.1016/b978-0-08-024408-2.50019-1 · Cited by 40 · see citing works

Electrophysiological and neurochemical correlates of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse

JONSSON, G., Sundstr�m, E., Mefford, I. N., et al. (1985) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00498844 · Cited by 17 · see citing works

Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease

Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Svendsen, C. N., & Heywood, P. (2003) · Nature Medicine · doi:10.1038/nm850 · Cited by 1,290 · see citing works

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

Nagahara, A. H., Merrill, D. A., Coppola, G., Tsukada, S., Schroeder, B. E., Shaked, G. M., Wang, L., Blesch, A., Kim, A., Conner, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1912 · Cited by 1,034 · see citing works

Functional recovery in parkinsonian monkeys treated with GDNF

Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P. A., Collins, F., et al. (1996) · Nature · doi:10.1038/380252a0 · Cited by 955 · see citing works

Adenosine receptors and brain diseases: neuroprotection and neurodegeneration

Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419 · see citing works

Short-Term GDNF Treatment Provides Long-Term Rescue of Lesioned Nigral Dopaminergic Neurons in a Rat Model of Parkinson’s Disease

Winkler, C., Sauer, H., Lee, C. S., & Björklund, A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-22-07206.1996 · Cited by 258 · see citing works

Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway

Wu, S.-Y., Wang, T.-F., Yu, L., Jen, C. J., Chuang, J.-I., Wu, F.-S., Wu, C.-W., & Kuo, Y.-M. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.09.006 · Cited by 206 · see citing works

Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease

Troncoso-Escudero, P., Parra, A., Nassif, M., & Vidal, R. L. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00860 · Cited by 191 · see citing works

Unilateral intraputamenal glial cell line–derived neurotrophic factor in patients with Parkinson disease: Response to 1 year of treatment and 1 year of withdrawal

Slevin, J. T., Gash, D. M., Smith, C. D., Gerhardt, G. A., Kryscio, R., Chebrolu, H., Walton, A., Wagner, R., & Young, A. B. (2007) · Journal of neurosurgery · doi:10.3171/jns.2007.106.4.614 · Cited by 173 · see citing works

Imaging of Peripheral Benzodiazepine Receptor Expression as Biomarkers of Detrimental versus Beneficial Glial Responses in Mouse Models of Alzheimer's and Other CNS Pathologies

Ji, B., Maeda, J., Sawada, M., Ono, M., Okauchi, T., Inaji, M., Zhang, M.-R., Suzuki, K., Ando, K., Staufenbiel, M., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2312-08.2008 · Cited by 169 · see citing works

Leptin Protects against 6-Hydroxydopamine-induced Dopaminergic Cell Death via Mitogen-activated Protein Kinase Signaling

Weng, Z., Signore, A. P., Gao, Y., Wang, S., Zhang, F., Hastings, T., Yin, X.-M., & Chen, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705426200 · Cited by 163 · see citing works

Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine

CASS, W. A., SMITH, M. P., & PETERS, L. E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.023 · Cited by 149 · see citing works

Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson’s disease

Yoshimoto, Y., Lin, Q., Collier, T. J., Frim, D. M., Breakefield, X. O., & Bohn, M. C. (1995) · Brain Research · doi:10.1016/0006-8993(95)00596-i · Cited by 146 · see citing works

Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor

Ding, Y. M., Jaumotte, J. D., Signore, A. P., & Zigmond, M. J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02415.x · Cited by 137 · see citing works

Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model

Kohl, Z., Winner, B., Ubhi, K., Rockenstein, E., Mante, M., Münch, M., Barlow, C., Carter, T., Masliah, E., & Winkler, J. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07933.x · Cited by 101 · see citing works

Microglia-mediated neuroinflammation and neurotrophic factor-induced protection in the MPTP mouse model of parkinson’s disease-lessons from transgenic mice

Machado, V., Zöller, T., Attaai, A., & Spittau, B. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020151 · Cited by 76 · see citing works

Effects of treadmill exercise on behavioral recovery and neural changes in the substantia nigra and striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse

Smith, B. A., Goldberg, N. R. S., & Meshul, C. K. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.003 · Cited by 67 · see citing works

Recombinant Adeno-Associated Virus Vector Expressing Glial Cell Line-Derived Neurotrophic Factor Reduces Ischemia-Induced Damage

Tsai, T.-H., Chen, S.-L., Chiang, Y.-H., Lin, S.-Z., Ma, H.-I., Kuo, S.-W., & Tsao, Y.-P. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7505 · Cited by 67 · see citing works

Acute and Chronic 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Administrations Elicit Similar Microglial Activation in the Substantia Nigra of Monkeys

Vázquez‐Claverie, M., Garrido‐Gil, P., Sebastián, W. S., Izal‐Azcárate, A., Belzunegui, S., Marcilla, I., López, B., & Luquín, M. R. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b35e41 · Cited by 44 · see citing works

Protective effect of Actinidia arguta in MPTP-induced Parkinson’s disease model mice

Kitamura, Y., Sakanashi, M., Ozawa, A., Saeki, Y., Nakamura, A., Hara, Y., Saeki, K., & Arimoto‐Kobayashi, S. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.03.116 · Cited by 15 · see citing works

Expression of c-Jun in dopaminergic neurons of the substantia nigra in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice

Nishi, K. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00862-7 · Cited by 33 · see citing works

Proteome analysis of substantia nigra and striatal tissue in the mouse MPTP model of Parkinson's disease

Zhao, X. S., Li, Q., Zhao, L., & Pu, X. (2007) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200700077 · Cited by 11 · see citing works

1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra

Langston, J. W., Irwin, I., Langston, E. B., & Forno, L. S. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90293-3 · Cited by 435 · see citing works